{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:05:08Z","timestamp":1794377108241,"version":"4.9.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41409-018-0164-y","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T02:16:27Z","timestamp":1522808187000},"page":"1288-1294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia"],"prefix":"10.1038","volume":"53","author":[{"given":"Vijaya Raj","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishal","family":"Gyawali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"164_CR1","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2009.813","volume":"301","author":"J Koreth","year":"2009","unstructured":"Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA. 2009;301:2349\u201361.","journal-title":"JAMA"},{"key":"164_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.leukres.2014.04.001","volume":"38","author":"AM Brunner","year":"2014","unstructured":"Brunner AM, Blonquist TM, Sadrzadeh H, Perry AM, Attar EC, Amrein PC, et al. Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysis. Leuk Res. 2014;38:773\u201380.","journal-title":"Leuk Res"},{"key":"164_CR3","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1002\/cncr.28129","volume":"119","author":"MS Thein","year":"2013","unstructured":"Thein MS, Ershler WB, Jemal A, Yates JW, Baer MR. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Cancer. 2013;119:2720\u20137.","journal-title":"Cancer"},{"key":"164_CR4","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1016\/S2352-3026(15)00148-9","volume":"2","author":"J Versluis","year":"2015","unstructured":"Versluis J, Hazenberg CL, Passweg JR, van Putten WL, Maertens J, Biemond BJ, et al. Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis. Lancet Haematol. 2015;2:e427\u2013436.","journal-title":"Lancet Haematol"},{"key":"164_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/2040620716643493","volume":"7","author":"G Goyal","year":"2016","unstructured":"Goyal G, Gundabolu K, Vallabhajosyula S, Silberstein PT, Bhatt VR. Reduced-intensity conditioning allogeneic hematopoietic-cell transplantation for older patients with acute myeloid leukemia. Ther Adv Hematol. 2016;7:131\u201341.","journal-title":"Ther Adv Hematol"},{"key":"164_CR6","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.bbmt.2013.06.008","volume":"1","author":"AM Brunner","year":"2013","unstructured":"Brunner AM, Kim HT, Coughlin E, Alyea EP 3rd, Armand P, Ballen KK, et al. Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant. 2013;1:1374\u201380.","journal-title":"Biol Blood Marrow Transplant"},{"key":"164_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bbmt.2009.12.537","volume":"1","author":"J Koreth","year":"2010","unstructured":"Koreth J, Aldridge J, Kim HT, Alyea EP 3rd, Cutler C, Armand P, et al. Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age. Biol Blood Marrow Transplant. 2010;1:792\u2013800.","journal-title":"Biol Blood Marrow Transplant"},{"key":"164_CR8","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1001\/jama.2011.1558","volume":"306","author":"ML Sorror","year":"2011","unstructured":"Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR, et al. Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. JAMA. 2011;306:1874\u201383.","journal-title":"JAMA"},{"key":"164_CR9","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1200\/JCO.2009.25.4821","volume":"28","author":"BL McClune","year":"2010","unstructured":"McClune BL, Weisdorf DJ, Pedersen TL, Tunes da Silva G, Tallman MS, Sierra J, et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol. 2010;28:1878\u201387.","journal-title":"J Clin Oncol"},{"key":"164_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bbmt.2011.07.013","volume":"18","author":"P Chevallier","year":"2012","unstructured":"Chevallier P, Szydlo RM, Blaise D, Tabrizi R, Michallet M, Uzunov M, et al. Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC. Biol Blood Marrow Transplant. 2012;18:289\u201394.","journal-title":"Biol Blood Marrow Transplant"},{"key":"164_CR11","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1200\/JCO.2015.62.7273","volume":"33","author":"SM Devine","year":"2015","unstructured":"Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, et al. Phase II study of allogeneic transplantation for older patients with acute myeloid leukemia in first complete remission using a reduced-intensity conditioning regimen: results from cancer and leukemia group B 100103 (Alliance for Clinical Trials in Oncology)\/Blood and Marrow Transplant Clinical Trial Network 0502. J Clin Oncol. 2015;33:4167\u201375.","journal-title":"J Clin Oncol"},{"key":"164_CR12","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.2014.60.4777","volume":"33","author":"YL Kasamon","year":"2015","unstructured":"Kasamon YL, Bolanos-Meade J, Prince GT, Tsai HL, McCurdy SR, Kanakry JA, et al. Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults. J Clin Oncol. 2015;33:3152\u201361.","journal-title":"J Clin Oncol"},{"key":"164_CR13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","volume":"130","author":"L Muffly","year":"2017","unstructured":"Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, et al. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. Blood. 2017;130:1156\u201364.","journal-title":"Blood"},{"key":"164_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.blre.2017.07.002","volume":"31","author":"SA Wall","year":"2017","unstructured":"Wall SA, Devine S, Vasu S. The who, how and why: allogeneic transplant for acute myeloid leukemia in patients older than 60 years. Blood Rev. 2017;31:362\u20139.","journal-title":"Blood Rev"},{"key":"164_CR15","unstructured":"O\u2019Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA et al. NCCN Clinical Practice Guidelines in Oncology. Acute Myeloid Leukemia version 3.2017. Available at \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf\n                    \n                  . Accessed on 6 Oct 2017."},{"key":"164_CR16","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/bmt.2013.67","volume":"48","author":"C Ustun","year":"2013","unstructured":"Ustun C, Lazarus HM, Weisdorf D. To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century. Bone Marrow Transplant. 2013;48:1497\u2013505.","journal-title":"Bone Marrow Transplant"},{"key":"164_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40258-013-0032-2","volume":"11","author":"J Meyers","year":"2013","unstructured":"Meyers J, Yu Y, Kaye JA, Davis KL. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy. 2013;11:275\u201386.","journal-title":"Appl Health Econ Health Policy"},{"key":"164_CR18","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3324\/haematol.2012.066100","volume":"97","author":"B Oran","year":"2012","unstructured":"Oran B, Weisdorf DJ. Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica. 2012;97:1916\u201324.","journal-title":"Haematologica"},{"issue":"1","key":"164_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/asheducation-2014.1.21","volume":"2014","author":"ML Sorror","year":"2014","unstructured":"Sorror ML, Estey E. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adults. Hematol Am Soc Hematol Educ Program. 2014;2014(1):21\u201333.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"164_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/bmt.2012.95","volume":"48","author":"J Pidala","year":"2013","unstructured":"Pidala J, Craig BM, Lee SJ, Majhail N, Quinn G, Anasetti C. Practice variation in physician referral for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2013;48:63\u201367.","journal-title":"Bone Marrow Transplant"},{"key":"164_CR21","unstructured":"National Cancer Data Base. Available at \n                    https:\/\/www.facs.org\/quality-programs\/cancer\/ncdb\/about\n                    \n                  . Accessed on 10 December 2016."},{"key":"164_CR22","unstructured":"Commission on Cancer. Apply for Accreditation. Requesting a Cancer Program Category Change. Available at \n                    https:\/\/www.facs.org\/quality-programs\/cancer\/coc\/apply\/categories\n                    \n                  . Accessed on 10 December 2016."},{"key":"164_CR23","unstructured":"National Cancer Data Base. Data Dictionary PUF 2014. Available at http:\/\/ncdbpuf.facs.org\/?q = print-pdf-all. Accessed on 10 Dec 2016."},{"key":"164_CR24","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1200\/JCO.2013.50.2567","volume":"31","author":"R Mawad","year":"2013","unstructured":"Mawad R, Gooley TA, Sandhu V, Lionberger J, Scott B, Sandmaier BM, et al. Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission. J Clin Oncol. 2013;31:3883\u20138.","journal-title":"J Clin Oncol"},{"key":"164_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/leu.2015.188","volume":"30","author":"AG Dinmohamed","year":"2016","unstructured":"Dinmohamed AG, Visser O, van Norden Y, Blijlevens NM, Cornelissen JJ, Huls GA, et al. Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012. Leukemia. 2016;30:24\u201331.","journal-title":"Leukemia"},{"key":"164_CR26","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.bbmt.2016.03.008","volume":"22","author":"VR Bhatt","year":"2016","unstructured":"Bhatt VR, Loberiza FR Jr., Schmit-Pokorny K, Lee SJ. Time to insurance approval in private and public payers does not influence survival in patients who undergo hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22:1117\u201324.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0164-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:52Z","timestamp":1684617112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0164-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0164-y","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"29 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}